NO20055891L - Kinazolinderivater som aurorakinaseinhibitorer - Google Patents

Kinazolinderivater som aurorakinaseinhibitorer

Info

Publication number
NO20055891L
NO20055891L NO20055891A NO20055891A NO20055891L NO 20055891 L NO20055891 L NO 20055891L NO 20055891 A NO20055891 A NO 20055891A NO 20055891 A NO20055891 A NO 20055891A NO 20055891 L NO20055891 L NO 20055891L
Authority
NO
Norway
Prior art keywords
quinazoline derivatives
aurorakinase
inhibitors
treatment
well
Prior art date
Application number
NO20055891A
Other languages
English (en)
Inventor
Frederic Henri Jung
Andrew Austen Mortlock
Nicola Murdoch Heron
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33522456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055891(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20055891L publication Critical patent/NO20055891L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Kinazolin-derivater med formel (I) for anvendelse ved behandling av proliferative sykdommer så som kreft, og ved fremstilling av medikamenter for anvendelse ved behandling av proliferative sykdommer, samt fremgangsmåter for fremstilling av dem, så vel som farmasøytiske preparater som inneholder dem som aktiv bestanddel.
NO20055891A 2003-06-17 2005-12-12 Kinazolinderivater som aurorakinaseinhibitorer NO20055891L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291463 2003-06-17
PCT/GB2004/002564 WO2004113324A1 (en) 2003-06-17 2004-06-14 Chinazoline derivatives as aurora kinase inhibitors

Publications (1)

Publication Number Publication Date
NO20055891L true NO20055891L (no) 2006-02-07

Family

ID=33522456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055891A NO20055891L (no) 2003-06-17 2005-12-12 Kinazolinderivater som aurorakinaseinhibitorer

Country Status (16)

Country Link
US (1) US20060178382A1 (no)
EP (1) EP1644361A1 (no)
JP (1) JP2006527748A (no)
KR (1) KR20060011891A (no)
CN (1) CN1835945A (no)
AR (1) AR045694A1 (no)
AU (1) AU2004249477A1 (no)
BR (1) BRPI0411503A (no)
CA (1) CA2529250A1 (no)
IL (1) IL172375A0 (no)
MX (1) MXPA05013825A (no)
NO (1) NO20055891L (no)
TW (1) TW200505452A (no)
UY (1) UY28366A1 (no)
WO (1) WO2004113324A1 (no)
ZA (1) ZA200510257B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2301981T3 (es) * 2003-04-16 2008-07-01 Astrazeneca Ab Derivados de quinazolina para el tratamiento del cancer.
EP1635837B1 (en) * 2003-06-02 2008-07-16 AstraZeneca AB (3-((quinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer
AU2005293336B2 (en) 2004-10-12 2009-05-28 Astrazeneca Ab Quinazoline derivatives
EP1812439B2 (en) 2004-10-15 2017-12-06 Takeda Pharmaceutical Company Limited Kinase inhibitors
US7358256B2 (en) * 2005-03-28 2008-04-15 Bristol-Myers Squibb Company ATP competitive kinase inhibitors
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
UY30183A1 (es) 2006-03-02 2007-10-31 Astrazeneca Ab Derivados de quinolina
EP1994023A1 (en) * 2006-03-02 2008-11-26 AstraZeneca AB Quinazoline derivatives
EP2040711A2 (en) * 2006-05-18 2009-04-01 Amphora Discovery Corporation 2-oxo-1,2-dihydroquinoline derivatives, compositions, and uses thereof as antiproliferative agents
GB0619342D0 (en) * 2006-09-30 2006-11-08 Vernalis R&D Ltd New chemical compounds
US20100120717A1 (en) 2006-10-09 2010-05-13 Brown Jason W Kinase inhibitors
US20110033461A1 (en) * 2008-03-12 2011-02-10 Vladimir Ratushny Combination Therapy for the Treatment of Cancer
JP7117323B2 (ja) * 2017-04-27 2022-08-12 アストラゼネカ・アクチエボラーグ フェノキシキナゾリン化合物及び癌の処置におけるそれらの使用
JP7128204B2 (ja) * 2017-04-27 2022-08-30 アストラゼネカ・アクチエボラーグ Ｃ５－アニリノキナゾリン化合物及び癌の処置におけるそれらの使用
KR20190043842A (ko) 2017-10-19 2019-04-29 건국대학교 산학협력단 피리미딘-2-아민 유도체, 이의 제조방법 및 이를 포함하는 항암제
CN110372666B (zh) * 2018-04-13 2022-11-08 华东理工大学 喹唑啉类化合物作为egfr三突变抑制剂及其应用
JP2022520907A (ja) * 2019-02-19 2022-04-01 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア Ｎｕｒｒ１受容体調節因子
KR102061458B1 (ko) 2019-08-14 2019-12-31 건국대학교 산학협력단 피리미딘-2-아민 유도체, 이의 제조방법 및 이를 포함하는 항암제
CN112939948B (zh) * 2019-12-11 2022-05-17 苏州美诺医药科技有限公司 新型含喹唑啉类化合物及其中间体与应用
CN113200964B (zh) * 2021-04-25 2022-07-05 南方医科大学南方医院 18f标记的egfr正电子显像剂及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
ATE394102T1 (de) * 2000-06-28 2008-05-15 Astrazeneca Ab Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
US7132427B2 (en) * 2001-06-21 2006-11-07 Ariad Pharmaceuticals, Inc. Quinazolines and uses thereof
IL162541A0 (en) * 2001-12-24 2005-11-20 Astrazeneca Ab Substituted quinazoline derivatives as inhibitors of aurora kinases

Also Published As

Publication number Publication date
ZA200510257B (en) 2007-05-30
AU2004249477A1 (en) 2004-12-29
JP2006527748A (ja) 2006-12-07
US20060178382A1 (en) 2006-08-10
WO2004113324A1 (en) 2004-12-29
EP1644361A1 (en) 2006-04-12
KR20060011891A (ko) 2006-02-03
MXPA05013825A (es) 2006-02-28
CA2529250A1 (en) 2004-12-29
UY28366A1 (es) 2005-01-31
BRPI0411503A (pt) 2006-07-25
CN1835945A (zh) 2006-09-20
TW200505452A (en) 2005-02-16
AR045694A1 (es) 2005-11-09
IL172375A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
NO20054842L (no) Kjemiske forbindelser
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
DK1636236T3 (da) Pyrazolo-quinazolin-derivater, en fremgangsmåde til fremstilling deraf, og deres anvendelse som kinase-inhibitorer
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
ATE400573T1 (de) 1h-imidazochinolinderivate als proteinkinaseinhibitoren
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
NO20061506L (no) Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
NO20072259L (no) Heteroaryltiazoler og deres anvendelse som P13K-inhibitorer
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
NO20092737L (no) Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
NO20053775L (no) Diazepinoindol derivater som kinaseinhibitorer.
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
NO20063768L (no) 1H-tieno[2,3c] pyrazolderivater anvendelige som kinaseinhibitorer
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
NO20054360L (no) Nye oxazolderivater, deres fremstilling og anvendelse som farmasotiske preparater
TW200502236A (en) Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
DE60214412D1 (de) Simplifizierte sarcodictyn-derivate als anti-tumor-mittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application